Daily non-political popular news in brief.

Comparison of immune response to 1918 and H5N1 influeza viruses shows similarities

A comparison of the 1918 Spanish influenza and the H5N1 avian influenza viruses suggests that while the two viruses appear to trigger a similar abnormal immune response in animal models, there are distinct differences. Researchers from the University of Washington School of Medicine in Seattle report their findings today at the ASM Biodefense and Emerging Disease Research Meeting.

Read more »

Keywords: comparison, immune, response, 1918, h5n1, influeza, viruses, shows, similarities, viruse, show, similarity

« Previous | Next »

Similar news on "Comparison of immune response to 1918 and H5N1 influeza viruses shows similarities":

1. New study may show how to forestall a fatal, virus-caused immune-system meltdown
   02-14-2007 · EurekAlert!
   Researchers at the University of Texas Medical Branch at Galveston believe they've found a way to spot the biochemical profile of an inappropriate immune response to viral infection -- an important step toward developing new therapies that may stop the fatal immune system meltdowns caused by such deadly pathogens as the Ebola, Marburg and Lassa fever viruses, as well as the virus strain responsible for the 1918 flu pandemic.
   Similar news · Read more »
   
2. Immune cell communication key to hunting viruses, Jefferson immunologists show
   10-25-2006 · EurekAlert!
   Immunologists have used nanotechnology to create a novel "biosensor" to solve in part a perplexing problem in immunology: how the immune system's killer T-cells hunt down invading viruses. They have found that surprisingly little virus can turn on killer T-cells, thanks to some complicated communication among "antigen presenting" proteins that recognize and attach to the virus, making it visible to the immune system. Presenting proteins cooperate, spreading a signal among receptors and boosting T-cell response.
   Similar news · Read more »
   
3. Scientists discover how cancer may take hold
   09-24-2007 · EurekAlert!
   A team, led by researchers at the Carnegie Institution, has found a key biochemical cycle that suppresses the immune response, thereby allowing cancer cells to multiply unabated. The research shows how the biomolecules responsible for healthy T cells, the body's first defenders against hostile invaders, are quashed, permitting the invading cancer to spread. The same cycle could also be involved in autoimmune diseases such as multiple sclerosis.
   Similar news · Read more »
   
4. Phase I study of novel gene therapy for HIV
   11-06-2006 · EurekAlert!
   The results are in for Phase I clinical trials of a gene therapy for AIDS. The trial was conducted at U-Penn where five patients with chronic HIV who had failed prior therapies were given a one-time infusion. They all tolerated the therapy and showed improved immune system response. This is the first publication of an effective gene therapy for AIDS to show positive clinical results in the peer review literature.
   Similar news · Read more »
   
5. A friendly foe -- Bacteria residing in the gut boost immune response to tumors
   07-26-2007 · EurekAlert!
   Total body irradiation (TBI), which depletes the body of lymphocytes, improves the ability of tumor-specific T cells to cause tumor regression. In a new JCI study researchers show that, in mice, lymphodepletion does not fully account for the tumor regression observed following TBI. They show that disruption of the population of bacteria that normally reside in the gut without causing disease also plays a role in the effectiveness of this therapeutic approach against cancer.
   Similar news · Read more »
   
6. Immune response to cancer stem cells may dictate cancer's course
   03-26-2007 · EurekAlert!
   Mounting evidence shows that a tumor's growth and spread may depend on "cancer stem cells," which comprise only a very small subset of the tumor. A new study by Rockefeller University scientists shows that immunity to cancer stem cells may help protect people with a precancerous condition from developing the full-blown disease, and that these cells could be an important target for cancer vaccines.
   Similar news · Read more »
   
7. SLU researchers show how to stop muscle weakness caused by myasthenia gravis
   12-20-2007 · EurekAlert!
   Severe muscle weakness caused by myasthenia gravis -- a highly debilitating autoimmune disorder -- can be prevented or reversed by blocking a key step in the immune response that brings on the disease, researchers at the Saint Louis University School of Medicine have found.
   Similar news · Read more »
   
8. New research shows how H5N1 virus causes disease
   09-27-2007 · EurekAlert!
   Researchers at Beijing University, Columbia University Mailman School of Public Health, and SUNY Downstate report in the Lancet detailed studies of human H5N1 victims that shed light on the anatomic distribution of the virus and its pathogenesis. Using a combination of molecular and protein labeling techniques, the authors found that H5N1 is present in the gastrointestinal tract and immune and central nervous systems, as well as the respiratory tract.
   Similar news · Read more »
   
9. How 'memory' T cells curb the spread of viruses throughout the body
   06-18-2007 · EurekAlert!
   A scientific discovery by Fox Chase Cancer Center researchers helps explain how "memory" T cells protect the body from viral diseases. The research published today in Proceedings of the National Academy of Science Online Early Edition shows lymph nodes are not just organs where immune cells reside and proliferate, but also are the sites where a major fight against the spread of an invading virus occurs.
   Similar news · Read more »
   
10. New vaccine against deadliest strain of avian flu tested by University of Pittsburgh scientists
    01-29-2008 · EurekAlert!
    A vaccine against the most common and deadliest strain of avian flu, H5N1, has been engineered and tested by researchers at the University of Pittsburgh's Center for Vaccine Research and Novavax, Inc. The vaccine produced a strong immune response in mice and protected them from death following infection with the H5N1 virus. The vaccine is being tested in humans in an early-phase clinical trial.
    Similar news · Read more »